Clinical evaluation of late outcomes in Dutch childhood cancer survivors: Methodology of the DCCSS LATER 2 study
Pediatric Blood & Cancer2023Vol. 70(5), pp. e30212–e30212
Citations Over TimeTop 1% of 2023 papers
Elizabeth A. M. Feijen, Jop C. Teepen, Eline van Dulmen‐den Broeder, Marry M. van den Heuvel‐Eibrink, Margriet van der Heiden‐van der Loo, Helena J. H. van der Pal, Andrica C. H. de Vries, Marloes Louwerens, Dorine Bresters, Birgitta Versluys, Hanneke de Ridder, Margreet A. Veening, Flora E. van Leeuwen, Martha A. Grootenhuis, Heleen Maurice‐Stam, Hanneke M. van Santen, Sebastian Neggers, Saskia M. F. Pluijm, Jaap den Hartogh, Cécile M. Ronckers, Wim J. E. Tissing, Jacqueline J. Loonen, Leontien C.M. Kremer
Abstract
The high-quality data generated in the LATER 2 study will provide valuable insights into risks of and risk factors for clinical and physical and psychosocial health outcomes and factors for early recognition of those health outcomes in long-term childhood cancer survivors. This will contribute to fill in important gaps in knowledge and improve the quality of life and care for childhood cancer survivors.
Related Papers
- → Psychosocial consequences of surviving cancer diagnosed and treated in childhood versus in adolescence/young adulthood: A call for clearer delineation between groups(2022)7 cited
- → Psychosocial Challenges of Childhood Cancer(1989)13 cited
- → Training in Long-Term Follow-Up: Fellowship in Childhood Cancer Survivorship(2020)
- → The Impact of Psychosocial Factors on Access to Care in Adult Minority Survivors of Childhood Cancer: A Childhood Cancer Survivor Study(2006)
- → MO29-3 Transition of childhood cancer survivors to adult care – what we have learned from the experience of Cancer Survivorship Clinic over the past 3 years(2023)